Xing Bao

1.4k total citations
31 papers, 1.1k citations indexed

About

Xing Bao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xing Bao has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Xing Bao's work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Xing Bao is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Xing Bao collaborates with scholars based in China. Xing Bao's co-authors include Tingting Ren, Shidong Wang, Bingxin Zheng, Kuisheng Liu, Yi Huang, Kunkun Sun, Wei Guo, Meng Li, Shan Wang and Wei Guo and has published in prestigious journals such as Scientific Reports, Sustainability and Dalton Transactions.

In The Last Decade

Xing Bao

30 papers receiving 1.1k citations

Peers

Xing Bao
Comparison fields: 5 of 100
  • Molecular Biology 623
  • Cancer Research 405
  • Oncology 260
  • Pulmonary and Respiratory Medicine 211
  • Epidemiology 124
Replace Guangjie Duan with:
Guangjie Duan China
Renquan Lu China
Wenjie Zheng China
Guangyu Yao China
Kai Zhu China
Shiji Fang China
Olga Martinho Portugal
Chunmeng Wang China
Jaroslav Truksa Czechia
Sheng Zhou China
Guangjie Duan China View profile →
Citations per field, relative to Xing Bao
Xing Bao · 1×
Citations per year, relative to Xing Bao
Xing Bao · 1×

Countries citing papers authored by Xing Bao

Since Specialization
Citations

This map shows the geographic impact of Xing Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Bao more than expected).

Fields of papers citing papers by Xing Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Bao. The network helps show where Xing Bao may publish in the future.

Co-authorship network of co-authors of Xing Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Bao. A scholar is included among the top collaborators of Xing Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Bao. Xing Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 8
3 14
4 75
5 18
6 2
7 17
8 64
9 27
10 46
11 114
12 93
13 24
14 1
15 229
16 23
17 17
18 54
19 54
20
BMPR2-pSMAD1/5 signaling pathway regulates RUNX2 expression and impacts the progression of dedifferentiated chondrosarcoma.
14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026